The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier.
The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier.
复制标题
DOI:
10.4103/1673-5374.369102
复制
发表时间:
2023-10
影响因子:
6.1
通讯作者:
Wang P
中科院分区:
文献类型:
--
作者:
Wei SS;Chen L;Yang FY;Wang SQ;Wang P
Remyelination failure is one of the main characteristics of multiple sclerosis and is potentially correlated with disease progression. Previous research has shown that the extracellular matrix is associated with remyelination failure because remodeling of the matrix often fails in both chronic and progressive multiple sclerosis. Fibronectin aggregates are assembled and persistently exist in chronic multiple sclerosis, thus inhibiting remyelination. Although many advances have been made in the mechanisms and treatment of multiple sclerosis, it remains very difficult for drugs to reach pathological brain tissues; this is due to the complexity of brain structure and function, especially the existence of the blood-brain barrier. Therefore, herein, we review the effects of fibronectin aggregates on multiple sclerosis and the efficacy of different forms of drug delivery across the blood-brain barrier in the treatment of this disease.
登录
查看更多内容
DOI:
10.1038/mt.2008.1
发表时间:
2008-04
期刊:
Molecular therapy : the journal of the American Society of Gene Therapy
影响因子:
--
作者:
Dai S;Wei D;Wu Z;Zhou X;Wei X;Huang H;Li G
通讯作者:
Li G
影响因子:
46.9
作者:
Alvarez-Erviti, Lydia;Seow, Yiqi;Wood, Matthew J. A.
通讯作者:
Wood, Matthew J. A.
影响因子:
6.1
作者:
Cherchi F;Pugliese AM;Coppi E
通讯作者:
Coppi E
影响因子:
0.9
作者:
Dragomir M;Chen B;Calin GA
通讯作者:
Calin GA
影响因子:
25
作者:
Dombrowski Y;O'Hagan T;Dittmer M;Penalva R;Mayoral SR;Bankhead P;Fleville S;Eleftheriadis G;Zhao C;Naughton M;Hassan R;Moffat J;Falconer J;Boyd A;Hamilton P;Allen IV;Kissenpfennig A;Moynagh PN;Evergren E;Perbal B;Williams AC;Ingram RJ;Chan JR;Franklin RJM;Fitzgerald DC
通讯作者:
Fitzgerald DC